Person › Details

Pascal Neuville (Domain Therapeutics S.A.)

Neuville, Pascal (Domain Therapeutics 200812c– CEO)

	Organisation	Domain Therapeutics S.A.
	Group	Domain Therapeutics (Group)
	Product	GPCR inhibitor
	Product 2	CNS drug

Record changed: 2018-12-04

More documents for Pascal Neuville

[1] Domain Therapeutics S.A.. (12/4/18). "Press Release: Domain Therapeutics Signs a Multi-target Research Collaboration and License Agreement with Boehringer Ingelheim on G Protein-Coupled Receptors (GPCRs) for Central Nervous System Disorders". Strasbour...
[2] Domain Therapeutics S.A.. (4/25/17). "Press Release: Pfizer Inc. and Domain Therapeutics Enter into a Collaboration Agreement on bioSensAll". Strasbourg & Montréal, ON....
[3] Merck KGaA. (1/23/17). "Press Release: Merck Announces Research Collaboration with Domain Therapeutics in Immuno-Oncology [Not intended for UK- or US-based media]". Darmstadt....
[4] Domain Therapeutics S.A.. (1/23/17). "Press Release: Domain Therapeutics and Merck Enter into a License and Collaboration Agreement for Development of Adenosine Receptor Antagonists in Immuno-oncology". Strasbourg....
[5] Ipsen S.A.. (3/8/16). "Press Release: Ipsen and PeptiMimesis Announce a Research Partnership in Oncology". Paris & Strasbourg....
[6] PeptiMimesis. (2/29/16). "Press Release: PeptiMimesis – New Biotech Startup Developing Next Generation Therapeutic Peptides in Immuno-oncology, Oncology and Immune Diseases". Strasbourg....
[7] Domain Therapeutics S.A.. (1/20/14). "Press Release: Domain Therapeutics Opens a North American Subsidiary at Montreal’s Neomed Institute". Strasbourg & Montréal, ON....
[8] University of Montreal. (12/18/13). "Press Release: Domain Therapeutics, Université de Montréal, IRICoR and McGill University Sign New Licensing and Partnership Agreement on G-Protein Coupled Receptor Biosensor Technology". Strasbourg & Montréal, ON....
[9] Domain Therapeutics S.A.. (7/17/12). "Press Release: Domain Therapeutics Closes 2 Million Euros Funding Round". Strasbourg....
[10] Domain Therapeutics S.A.. (1/30/12). "Press Release: Domain Therapeutics Awarded Grant from The Michael J. Fox Foundation for the Development of Novel mGluR3 PAM Compounds to Treat Parkinson’s Disease". Strasbourg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

» top

Top News

Upcoming Events

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Partners

Pascal Neuville (Domain Therapeutics S.A.)

More documents for Pascal Neuville